Glioblastoma multiforme (GBM) is the most aggressive and common malignant primary brain
tumor. Patients with GBM often have poor prognoses, with a median survival of∼ 15 months …

Simple Summary Artificial intelligence (AI) is the branch of computer science that enables
machines to learn, reason, and problem solve. In recent decades, AI has been developed …

Background New precision medicine therapies are urgently required for glioblastoma
(GBM). However, to date, efforts to subtype patients based on molecular profiles have failed …

While immunotherapy has emerged as a promising strategy to treat glioblastoma multiforme
(GBM), the limited availability of immunotherapeutic agents in tumors due to the presence of …

Glioblastoma (GBM) is an aggressive type of cancer that has led to the death of a large
population. The traditional approach fails to develop a solution for GBM's suffering life …

Here, we describe a blood test for the detection of glial malignancies (GLI‐M) based on the
identification of circulating glial cells (CGCs). The test is highly specific for GLI‐M and can …

Lactoferrin (Lf)—a glycoprotein of the transferrin family—has been investigated as a
promising molecule with diverse applications, including infection inhibition, anti …

Bromodomain and extraterminal proteins (BET) play key roles in regulation of gene
expression, and may play a role in cancer-cell proliferation, survival, and oncogenic …

Glioma is the most common and aggressive tumor of the central nervous system. The
uncontrolled proliferation, cellular heterogeneity, and diffusive capacity of glioma cells …

Background Glioblastoma (GBM) is a highly malignant brain tumor that affects men more
often than women. In addition, the former shows a poorer survival prognosis. To date, the …